Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) / Masato Yoneda ... [et al.].

Saved in:
Bibliographic Details
Superior document:Metabolic diseases--laboratory and clinical research
:
TeilnehmendeR:
Year of Publication:2010
Language:English
Series:Metabolic diseases--laboratory and clinical research series.
Novinka (Series)
Online Access:
Physical Description:viii, 54 p. :; col. ill.
Tags: Add Tag
No Tags, Be the first to tag this record!
id 5003020935
ctrlnum (MiAaPQ)5003020935
(Au-PeEL)EBL3020935
(CaPaEBR)ebr10681073
(OCoLC)923664583
collection bib_alma
record_format marc
spelling Yoneda, Masato.
Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) [electronic resource] / Masato Yoneda ... [et al.].
New York : Nova Biomedical Books, c2010.
viii, 54 p. : col. ill.
Metabolic diseases--laboratory and clinical research
Novinka
Includes bibliographical references and index.
NAFLD and insulin resistance (IR) -- Pathophysiology of NASH : insulin resistance, free fatty acids, and cytokines -- Adiponectin and NASH -- TNF-[alpha] and NAFLD/NASH -- Leptin and NAFLD/NASH -- Peroxisome proliferators-activated receptors (PPARs) and NAFLD/NASH -- Iron overload and NAFLD/NASH -- Mitochondrial abnormalities and NAFLD/NASH -- Genetic influences in NAFLD/NASH -- Therapeutic strategy for NASH patients -- Natural history of NAFLD -- Conclusions.
Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
Fatty liver.
Insulin resistance.
Electronic books.
ProQuest (Firm)
Metabolic diseases--laboratory and clinical research series.
Novinka (Series)
https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3020935 Click to View
language English
format Electronic
eBook
author Yoneda, Masato.
spellingShingle Yoneda, Masato.
Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH)
Metabolic diseases--laboratory and clinical research
Novinka
NAFLD and insulin resistance (IR) -- Pathophysiology of NASH : insulin resistance, free fatty acids, and cytokines -- Adiponectin and NASH -- TNF-[alpha] and NAFLD/NASH -- Leptin and NAFLD/NASH -- Peroxisome proliferators-activated receptors (PPARs) and NAFLD/NASH -- Iron overload and NAFLD/NASH -- Mitochondrial abnormalities and NAFLD/NASH -- Genetic influences in NAFLD/NASH -- Therapeutic strategy for NASH patients -- Natural history of NAFLD -- Conclusions.
author_facet Yoneda, Masato.
ProQuest (Firm)
ProQuest (Firm)
author_variant m y my
author2 ProQuest (Firm)
author2_role TeilnehmendeR
author_corporate ProQuest (Firm)
author_sort Yoneda, Masato.
title Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH)
title_full Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) [electronic resource] / Masato Yoneda ... [et al.].
title_fullStr Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) [electronic resource] / Masato Yoneda ... [et al.].
title_full_unstemmed Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) [electronic resource] / Masato Yoneda ... [et al.].
title_auth Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH)
title_new Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH)
title_sort insulin resistance and nonalcoholic fatty liver disease (nafld)/nonalcoholic steatohepatitis (nash)
series Metabolic diseases--laboratory and clinical research
Novinka
series2 Metabolic diseases--laboratory and clinical research
Novinka
publisher Nova Biomedical Books,
publishDate 2010
physical viii, 54 p. : col. ill.
contents NAFLD and insulin resistance (IR) -- Pathophysiology of NASH : insulin resistance, free fatty acids, and cytokines -- Adiponectin and NASH -- TNF-[alpha] and NAFLD/NASH -- Leptin and NAFLD/NASH -- Peroxisome proliferators-activated receptors (PPARs) and NAFLD/NASH -- Iron overload and NAFLD/NASH -- Mitochondrial abnormalities and NAFLD/NASH -- Genetic influences in NAFLD/NASH -- Therapeutic strategy for NASH patients -- Natural history of NAFLD -- Conclusions.
isbn 9781617284809 (electronic bk.)
callnumber-first R - Medicine
callnumber-subject RC - Internal Medicine
callnumber-label RC848
callnumber-sort RC 3848 F3 Y66 42010
genre Electronic books.
genre_facet Electronic books.
url https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3020935
illustrated Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 616 - Diseases
dewey-full 616.3/62
dewey-sort 3616.3 262
dewey-raw 616.3/62
dewey-search 616.3/62
oclc_num 923664583
work_keys_str_mv AT yonedamasato insulinresistanceandnonalcoholicfattyliverdiseasenafldnonalcoholicsteatohepatitisnash
AT proquestfirm insulinresistanceandnonalcoholicfattyliverdiseasenafldnonalcoholicsteatohepatitisnash
status_str n
ids_txt_mv (MiAaPQ)5003020935
(Au-PeEL)EBL3020935
(CaPaEBR)ebr10681073
(OCoLC)923664583
hierarchy_parent_title Metabolic diseases--laboratory and clinical research
Novinka
is_hierarchy_title Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH)
container_title Metabolic diseases--laboratory and clinical research
author2_original_writing_str_mv noLinkedField
_version_ 1792330833102635009
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02052nam a2200421 a 4500</leader><controlfield tag="001">5003020935</controlfield><controlfield tag="003">MiAaPQ</controlfield><controlfield tag="005">20200520144314.0</controlfield><controlfield tag="006">m o d | </controlfield><controlfield tag="007">cr cn|||||||||</controlfield><controlfield tag="008">100616s2010 nyua sb 001 0 eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="z"> 2010025523</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9781616689278 (softcover)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">1616689277 (softcover)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781617284809 (electronic bk.)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)5003020935</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Au-PeEL)EBL3020935</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaPaEBR)ebr10681073</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)923664583</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MiAaPQ</subfield><subfield code="c">MiAaPQ</subfield><subfield code="d">MiAaPQ</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC848.F3</subfield><subfield code="b">Y66 2010</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.3/62</subfield><subfield code="2">22</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Yoneda, Masato.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH)</subfield><subfield code="h">[electronic resource] /</subfield><subfield code="c">Masato Yoneda ... [et al.].</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">New York :</subfield><subfield code="b">Nova Biomedical Books,</subfield><subfield code="c">c2010.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">viii, 54 p. :</subfield><subfield code="b">col. ill.</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Metabolic diseases--laboratory and clinical research</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Novinka</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">NAFLD and insulin resistance (IR) -- Pathophysiology of NASH : insulin resistance, free fatty acids, and cytokines -- Adiponectin and NASH -- TNF-[alpha] and NAFLD/NASH -- Leptin and NAFLD/NASH -- Peroxisome proliferators-activated receptors (PPARs) and NAFLD/NASH -- Iron overload and NAFLD/NASH -- Mitochondrial abnormalities and NAFLD/NASH -- Genetic influences in NAFLD/NASH -- Therapeutic strategy for NASH patients -- Natural history of NAFLD -- Conclusions.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="a">Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Fatty liver.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Insulin resistance.</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic books.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">ProQuest (Firm)</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Metabolic diseases--laboratory and clinical research series.</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Novinka (Series)</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3020935</subfield><subfield code="z">Click to View</subfield></datafield></record></collection>